Research Progress in the Adjuvant Treatment of non-small Cell Lung Cancer with Chinese Medicine Injections-Reference-Cited by-同舟云学术

Research Progress in the Adjuvant Treatment of non-small Cell Lung Cancer with Chinese Medicine Injections

Published:2024-08-21 Issue:8 Volume:6 Page:127-132
ISSN:2006-2745
Container-title:Journal of Contemporary Medical Practice
language:
Short-container-title:JCMP

Author:

Cao Yixuan,Si Hailong

Abstract

Non-small cell lung cancer (NSCLC) is a common type of lung cancer. Patients with advanced NSCLC often lose the chance of surgery. Integrated traditional Chinese and western medicine therapy, especially traditional Chinese medicine injection, has shown its advantages in the treatment of non-small cell lung cancer. It plays an anti-cancer role by inhibiting cell proliferation, promoting apoptosis, inhibiting tumor invasion and metastasis, and improving anti-tumor drug resistance. It has shown advantages in reducing adverse reactions, improving efficacy and quality of life of patients.

Publisher

Century Science Publishing Co

Reference49 articles.

1. Oncology Society of Chinese Medical Association, Chinese Medical Association Publishing House. Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2023 edition) [J]. Zhonghua Zhongliu Zazhi, 2023, 45(7): 539-574.

2. Passaro A, Leighl N, Blackhall F, et al. ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer [J]. Ann Oncol, 2022, 33(5): 466-487.

3. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.

4. Jin M H, Tang J, Qin J L, et al. Epidemiological analysis of lung cancer from 2002 to 2020 [J]. Chinese Journal of Medicine, 2019, 34(6):34-38.

5. Pi Weiping. Research on Chinese medicine evidence and identification and typing of non-small cell lung cancer [D]. Beijing: Beijing University of Chinese Medicine, 2017.